Phase 3 trial assesses clazakizumab in kidney transplant recipients with caAMR27 Oct 2024, 23:42 · News-MedicalStudy: "Clazakizumab in Chronic Active Antibody-Mediated Kidney Transplant Rejection: Results of the IMAGINE Phase 3 Study"Source:American Society of Nephrology